The Immunofluorescence Assay Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Immunofluorescence Assay Market?
The size of the immunofluorescence assay market has substantially increased over recent years. The market was valued at $3.34 billion in 2024 and is projected to increase to $3.59 billion in 2025. This represents a compound annual growth rate (CAGR) of 7.4%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Immunofluorescence Assay Industry?
The Immunofluorescence Assay Global Market Report 2025 predicts that the market value will rise to $5.4 billion in 2029, with a compound annual growth rate (CAGR) of 10.7%.
Download Your Free Sample of the 2025 Immunofluorescence Assay Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Immunofluorescence Assay Market?
The key drivers in the immunofluorescence assay market are:
• Escalation in personalized medicine application
• Increasing surveillance of infectious diseases
• Rising incidence of autoimmune disorders
• Expansion in point-of-care testing
• Improvement in global health preparedness
Global Market Segmentation: Identifying Major Immunofluorescence Assay Industry Segments
The immunofluorescence assay market covered in this report is segmented –
1) By Type: Direct Immunofluorescence, Indirect Immunofluorescence
2) By Product: Reagents, Instruments, Antibodies, Kits, Consumables and Accessories
3) By Disease: Cancer, Infectious Disease, Cardiovascular Diseases, Autoimmune Diseases, Other Diseases
4) By End User: Academic And Research Institutions, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Hospitals And Diagnostic Centers
Pre-order the 2025 Immunofluorescence Assay Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Immunofluorescence Assay Market?
The key trends in the ultra-wideband market are:
• Multiplexing assays are an emerging trend in the market.
• Automation and robotics are significantly shaping the future of the market.
• High-content imaging is an upcoming trend.
• There is a rise in the integration of digital pathology.
Who Are the Top Competitors & Leading Players in the Immunofluorescence Assay Market?
Major companies in the immunofluorescence assay market are:
• Thermo Fisher Scientific Inc.
• Abcam plc
• PerkinElmer Inc.
• Werfen Company
• Merck KGaA
• Danaher Corporation
• Cell Signaling Technology Inc.
• Vector Laboratories Inc.
• INOVA Diagnostics Inc.
• Sino Biological Inc.
• Medipan GmbH
• BioLegend Inc.
• Jackson ImmunoResearch Laboratories Inc.
• Rockland Immunochemicals Inc.
• Bethyl Laboratories Inc.
• Fitzgerald Industries International Inc.
• Creative Diagnostics
• Boster Biological Technology
• Acris Antibodies GmbH
• RayBiotech Inc.
• Proteintech Group Inc.
• Novus Biologicals LLC
• R&D Systems Inc.
• OriGene Technologies Inc.
• GenScript Biotech Corporation
• MBL International Corporation
• Abnova Corporation
• Cellabs India Technologies Limited
• J. Mitra & Co. Pvt. Ltd.
• EpiGentek Group Inc.
• Elabscience Biotechnology Co. Ltd.
• Aesku.Diagnostics GmbH
Regional Dominance: Which Area Leads the Global Immunofluorescence Assay Market?
North America was the largest region in the immunofluorescence assay market in 2024, and it is also expected to be the fastest-growing region in the forecast period
